tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

SAGE Stock Latest News

SAGE Therapeutics Faces Legal Challenges: Potential Impact on Financial Stability and Growth
Company AnnouncementsSAGE Therapeutics Faces Legal Challenges: Potential Impact on Financial Stability and Growth
8d ago
SAGE
Hold Rating for SAGE Therapeutics: Inventory Challenges and Strategic Prospects
PremiumRatings
Hold Rating for SAGE Therapeutics: Inventory Challenges and Strategic Prospects
8d ago
SAGE
SAGE Therapeutics’ Earnings Call: ZURZUVAE’s Success Amid Challenges
PremiumCompany Announcements
SAGE Therapeutics’ Earnings Call: ZURZUVAE’s Success Amid Challenges
8d ago
SAGE
Sage Therapeutics price target lowered to $12 from $14 at Scotiabank
PremiumThe Fly
Sage Therapeutics price target lowered to $12 from $14 at Scotiabank
8d ago
BIIB
SAGE
Sage Therapeutics price target lowered to $7 from $9 at Baird
PremiumThe Fly
Sage Therapeutics price target lowered to $7 from $9 at Baird
8d ago
SAGE
Cautious Outlook on SAGE Therapeutics Amid Strategic Uncertainty and Pipeline Ambiguities
PremiumRatingsCautious Outlook on SAGE Therapeutics Amid Strategic Uncertainty and Pipeline Ambiguities
8d ago
SAGE
Sage Therapeutics price target lowered to $8 from $9 at Canaccord
Premium
The Fly
Sage Therapeutics price target lowered to $8 from $9 at Canaccord
8d ago
BIIB
SAGE
SAGE Therapeutics: Hold Rating Amid Uncertainty and Strategic Exploration
Premium
Ratings
SAGE Therapeutics: Hold Rating Amid Uncertainty and Strategic Exploration
8d ago
SAGE
Hold Rating on SAGE Therapeutics Amid Underwhelming Sales and Strategic Uncertainties
PremiumRatings
Hold Rating on SAGE Therapeutics Amid Underwhelming Sales and Strategic Uncertainties
8d ago
SAGE
Sage Therapeutics price target lowered to $12 from $14 at H.C. Wainwright
PremiumThe Fly
Sage Therapeutics price target lowered to $12 from $14 at H.C. Wainwright
8d ago
SAGE
Sage Therapeutics Reports Strong 2024 Performance
PremiumCompany Announcements
Sage Therapeutics Reports Strong 2024 Performance
9d ago
SAGE
SAGE Therapeutics: Hold Rating Amid Financial Challenges and Uncertain Outlook
PremiumRatings
SAGE Therapeutics: Hold Rating Amid Financial Challenges and Uncertain Outlook
9d ago
SAGE
Sage Therapeutics says existing cash to support operations through mid-2027
PremiumThe FlySage Therapeutics says existing cash to support operations through mid-2027
9d ago
SAGE
Sage Therapeutics reports Q4 EPS , consensus ($1.36)
Premium
The Fly
Sage Therapeutics reports Q4 EPS , consensus ($1.36)
9d ago
SAGE
SAGE Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
SAGE Earnings Report this Week: Is It a Buy, Ahead of Earnings?
11d ago
SAGE
Sage Therapeutics price target raised to $9 from $6 at Mizuho
PremiumThe Fly
Sage Therapeutics price target raised to $9 from $6 at Mizuho
22d ago
BIIB
SAGE
Sage Rejects Biogen Bid but Could be Open to Other Offers
PremiumMarket News
Sage Rejects Biogen Bid but Could be Open to Other Offers
23d ago
BIIB
SAGE
M&A News: Sage Rejects Biogen’s $469M Takeover Bid over Valuation Concerns
PremiumMarket News
M&A News: Sage Rejects Biogen’s $469M Takeover Bid over Valuation Concerns
23d ago
BIIB
China’s DeepSeek sinks tech, AT&T reports Q4 beat: Morning Buzz
PremiumThe Fly
China’s DeepSeek sinks tech, AT&T reports Q4 beat: Morning Buzz
24d ago
T
JD
Sage Therapeutics initiates strategic review, rejects Biogen proposal
PremiumThe FlySage Therapeutics initiates strategic review, rejects Biogen proposal
24d ago
BIIB
SAGE
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
1M ago
ARDX
CGEN
J&J to acquire Intra-Cellular, Clearwater to buy Enfusion: Morning Buzz
Premium
The Fly
J&J to acquire Intra-Cellular, Clearwater to buy Enfusion: Morning Buzz
1M ago
M
BX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >